Ratiopharm competitive analysis

Loading summary...

Explore patent oppositions filed by Ratiopharm against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 6, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTFeb 26, 2025

Explore Ratiopharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 6, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 19, 2017Pharmaceutical Formulation Comprising Ezetimibe4

Latest PTAB cases involving Ratiopharm

Discover the latest PTAB cases involving Ratiopharm, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ratiopharm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
RATIOPHARM14 - -
BULLE DR19 - - -
HGF74 - - -
HOFFMANN EITLE148 - - -